Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Timolol Maleate 0.5% Compared to Brinzolamide 1% When Added to Travoprost 0.004% in Primary Open-angle Glaucoma or Ocular Hypertension

NCT00372827 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00372827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Timolol Maleate 0.5% Compared to Brinzolamide 1% When Added to Travoprost 0.004% in Primary Open-angle Glaucoma or Ocular Hypertension
Lead sponsor
Alcon Research
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2004
Completion date
January 31, 2006
Enrollment
245
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, pigment dispersion glaucoma, primary open-angle glaucoma